Safety and Efficacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis

Safety and Efficacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis

Katsuaki Ogushi,1,* Makoto Chuma,1,* Haruki Uojima,2 Hisashi Hidaka,2 Kazushi Numata,1 Satoshi Kobayashi,3 Shunji Hirose,4 Nobuhiro Hattori,5 Tomoaki Fujikawa,6 Takahide Nakazawa,2 Naohisa Wada,2 Shuitirou Iwasaki,2 Taito Fukushima,3 Yusuke Sano,3 Makoto Ueno,3 Kuniyuki Kawano,3 Kota Tsuruya,4 Masak...

Full description

Bibliographic Details
Main Authors: Ogushi K, Chuma M, Uojima H, Hidaka H, Numata K, Kobayashi S, Hirose S, Hattori N, Fujikawa T, Nakazawa T, Wada N, Iwasaki S, Fukushima T, Sano Y, Ueno M, Kawano K, Tsuruya K, Shomura M, Watanabe T, Matsunaga K, Kunishi Y, Saigusa Y, Irie K, Iwabuchi S, Kako M, Morimoto M, Kagawa T, Tanaka K, Maeda S
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Clinical and Experimental Gastroenterology
Subjects:
lenvatinib
tyrosine kinase inhibitor
hepatocellular carcinoma
child-pugh
adverse events
overall survival
Online Access:https://www.dovepress.com/safety-and-efcacy-of-lenvatinib-treatment-in-childndashpugh-a-and-b-pa-peer-reviewed-article-CEG

Internet

https://www.dovepress.com/safety-and-efcacy-of-lenvatinib-treatment-in-childndashpugh-a-and-b-pa-peer-reviewed-article-CEG

Similar Items